Strategic Integration Bend Research is now part of Capsugel Dosage Form Solutions, indicating access to broader capabilities in dosage form design, polymer science, and capsule technology which can open cross-sell opportunities to Capsugel clients needing specialty delivery solutions.

Expanded Capabilities Leverage Capsugel's global footprint and proprietary technologies to pitch integrated development services from formulation through manufacturing, enabling customers to accelerate time to market for complex biopharmaceutical and consumer health products.

Formulation Expertise Highlight Bend Research’s extensive formulation know-how and capsule science as a differentiator for clients seeking optimization of bioavailability and targeted delivery across a wide range of dosage forms.

Mid-market Growth With estimated revenue in the $100M–$250M range and a medium employer base, target mid-size pharma, contract development and manufacturing organizations (CDMOs), and nutraceutical players looking for scalable, high-value dosage form solutions.

Innovation Pipeline Position the combined entity as a conduit for proprietary, patent-protected technologies and rapid design capability to address evolving customer needs, creating opportunities for licensing, co-development, and long-term collaborations.